Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Ms. Alexandra BalcomCFO & Treasurer | -11,43k | 1,05M | Derivative Exercise and Sale | 6,89 - 103,84 | 85,53k | - |
| 2026-05-28 | Ms. Darlene NociChief Development Officer | -5,50k | 439,75k | Derivative Exercise and Sale | 27,85 - 109,76 | 17,02k | - |
| 2026-05-28 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5,50k | 555,21k | Derivative Exercise and Sale | 6,89 - 109,30 | 18,53k | - |
| 2026-05-04 | Dr. James R. PorterCEO, President & Director | -30,00k | 2,48M | Derivative Exercise and Sale | 18,93 - 102,88 | 203,53k | - |
| 2026-05-01 | Ms. Alexandra BalcomCFO & Treasurer | -11,43k | 1,09M | Derivative Exercise and Sale | 1,08 - 99,97 | 85,53k | - |
| 2026-04-30 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5,50k | 507,80k | Derivative Exercise and Sale | 6,89 - 99,57 | 18,53k | - |
| 2026-04-29 | Ms. Darlene NociChief Development Officer | -5,50k | 394,35k | Derivative Exercise and Sale | 27,85 - 101,17 | 17,02k | - |
| 2026-04-09 | Dr. Henry PelishChief Scientific Officer | -3,09k | 237,02k | Derivative Exercise and Sale | 27,85 - 105,00 | 20,14k | - |
| 2026-04-06 | Dr. James R. PorterCEO, President & Director | -30,00k | 2,40M | Derivative Exercise and Sale | 18,93 - 105,60 | 203,53k | - |
| 2026-04-01 | Ms. Alexandra BalcomCFO & Treasurer | -11,43k | 1,19M | Derivative Exercise and Sale | 1,08 - 106,18 | 85,53k | - |
| 2026-03-30 | Ms. Darlene NociChief Development Officer | -5,50k | 384,77k | Derivative Exercise and Sale | 27,85 - 98,13 | 17,02k | - |
| 2026-03-26 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5,50k | 505,10k | Derivative Exercise and Sale | 6,89 - 99,46 | 18,53k | - |
| 2026-03-25 | Ms. Alexandra BalcomCFO & Treasurer | -13,70k | 1,37M | Automatic Disposition | 100,16 | 44,43k | -23,57% |
| 2026-03-24 | Ms. Alexandra BalcomCFO & Treasurer | -11,43k | 1,08M | Derivative Exercise and Sale | 1,08 - 96,50 | 44,43k | - |
| 2026-03-12 | Dr. Henry PelishChief Scientific Officer | -17,32k | 1,15M | Derivative Exercise and Sale | 18,93 - 97,79 | 20,14k | - |
| 2026-03-12 | Dr. Henry PelishChief Scientific Officer | -17,78k | 1,75M | Automatic Disposition | 97,79 - 99,71 | 20,14k | -46,90% |
| 2026-03-06 | Dr. James R. PorterCEO, President & Director | -30,00k | 2,13M | Derivative Exercise and Sale | 27,85 - 100,19 | 203,53k | - |
| 2026-02-26 | Ms. Darlene NociChief Development Officer | -5,50k | 413,51k | Derivative Exercise and Sale | 27,85 - 104,25 | 17,02k | - |
| 2026-02-26 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5,50k | 528,89k | Derivative Exercise and Sale | 6,89 - 103,96 | 18,53k | - |
| 2026-01-29 | Ms. Darlene NociChief Development Officer | -5,50k | 408,25k | Derivative Exercise and Sale | 27,85 - 103,39 | 17,02k | - |
| 2026-01-21 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -15,00k | 1,23M | Derivative Exercise and Sale | 27,85 - 110,16 | 18,53k | - |
| 2026-01-05 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -6,95k | 676,16k | Verkauf | 96,06 - 98,52 | 18,53k | -27,28% |
| 2026-01-05 | Ms. Darlene NociChief Development Officer | -7,42k | 721,32k | Verkauf | 96,06 - 98,52 | 17,02k | -30,36% |
| 2026-01-05 | Dr. Henry PelishChief Scientific Officer | -5,16k | 501,75k | Verkauf | 96,06 - 98,52 | 24,46k | -17,42% |
| 2026-01-05 | Ms. Alexandra BalcomCFO & Treasurer | -7,42k | 721,32k | Verkauf | 96,06 - 98,52 | 58,13k | -11,32% |
| 2026-01-05 | Dr. Christopher D. TurnerChief Medical Officer | -7,42k | 721,32k | Verkauf | 96,06 - 98,52 | 31,53k | -19,04% |
| 2026-01-05 | Dr. James R. PorterCEO, President & Director | -27,43k | 2,67M | Verkauf | 96,06 - 98,52 | 203,53k | -11,88% |
| 2026-01-02 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -10,00k | 815,81k | Derivative Exercise and Sale | 18,93 - 101,47 | 8,14k | - |
| 2025-12-30 | Ms. Darlene NociChief Development Officer | -4,00k | 288,78k | Derivative Exercise and Sale | 27,85 - 101,22 | 48,03k | - |
| 2025-12-22 | Ms. Alexandra BalcomCFO & Treasurer | 34,50k | 37,26k | Derivative Exercise and Retained Stock | 1,08 | 48,20k | 251,82% |
| 2025-12-22 | Dr. Henry PelishChief Scientific Officer | 5,09k | 5,49k | Derivative Exercise and Retained Stock | 1,08 | 30,10k | 20,33% |
| 2025-12-19 | Dr. James R. PorterCEO, President & Director | 57,00k | 37,05k | Derivative Exercise and Retained Stock | 0,65 | 174,61k | 48,46% |
| 2025-12-08 | Ms. Alexandra BalcomCFO & Treasurer | -7,08k | 781,54k | Automatic Disposition | 110,31 - 111,32 | 13,70k | -34,08% |
| 2025-11-28 | Ms. Darlene NociChief Development Officer | -4,00k | 322,92k | Derivative Exercise and Sale | 27,85 - 108,72 | 48,03k | - |
| 2025-11-24 | Prof. Matthew D. ShairInsider | -7,50k | 820,27k | Automatic Disposition | 107,70 - 110,42 | 1,58M | -0,47% |
| 2025-11-24 | Deerfield Management Company, L.P.Unternehmen | -742,57k | 70,87M | Verkauf | 95,45 | 17,25M | -4,13% |
| 2025-11-17 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -24,20k | 2,39M | Derivative Exercise and Sale | 6,89 - 107,04 | 8,14k | - |
| 2025-11-17 | Ms. Alexandra BalcomCFO & Treasurer | -20,73k | 1,02M | Derivative Exercise and Sale | 6,89 - 104,54 | 20,78k | - |
| 2025-10-30 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -21,80k | 2,10M | Derivative Exercise and Sale | 6,89 - 104,78 | 8,14k | - |
| 2025-10-30 | Ms. Darlene NociChief Development Officer | -4,00k | 300,26k | Derivative Exercise and Sale | 27,85 - 104,58 | 48,03k | - |
| 2025-10-27 | Prof. Matthew D. ShairInsider | -60,00k | 6,02M | Automatic Disposition | 100,23 - 100,27 | 1,58M | -3,65% |
| 2025-10-20 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5,00k | 440,10k | Derivative Exercise and Sale | 6,89 - 94,91 | 8,14k | - |
| 2025-10-16 | Dr. James R. PorterCEO, President & Director | -27,00k | 1,94M | Derivative Exercise and Sale | 18,93 - 92,63 | 117,61k | - |
| 2025-10-15 | Dr. Henry PelishChief Scientific Officer | -14,21k | 780,76k | Derivative Exercise and Sale | 18,93 - 90,04 | 25,01k | - |
| 2025-10-15 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -28,00k | 2,35M | Derivative Exercise and Sale | 6,89 - 92,50 | 8,14k | - |
| 2025-10-15 | Ms. Alexandra BalcomCFO & Treasurer | -1,68k | 112,16k | Derivative Exercise and Sale | 18,93 - 85,57 | 20,78k | - |
| 2025-10-13 | Dr. Henry PelishChief Scientific Officer | -10,07k | 554,22k | Derivative Exercise and Sale | 18,93 - 89,81 | 25,01k | - |
| 2025-10-13 | Ms. Alexandra BalcomCFO & Treasurer | -40,00k | 2,82M | Derivative Exercise and Sale | 6,89 - 89,22 | 20,78k | - |
| 2025-10-01 | Ms. Alexandra BalcomCFO & Treasurer | -20,00k | 1,53M | Derivative Exercise and Sale | 6,89 - 86,37 | 20,78k | - |
| 2025-09-29 | Ms. Alexandra BalcomCFO & Treasurer | -27,59k | 2,16M | Derivative Exercise and Sale | 6,89 - 85,06 | 20,78k | - |
| 2025-09-29 | Ms. Darlene NociChief Development Officer | -4,00k | 220,89k | Derivative Exercise and Sale | 27,85 - 84,92 | 7,08k | - |
| 2025-09-15 | Dr. James R. PorterCEO, President & Director | -27,00k | 1,62M | Derivative Exercise and Sale | 18,93 - 80,12 | 117,61k | - |
| 2025-09-10 | Dr. Henry PelishChief Scientific Officer | -3,73k | 193,29k | Derivative Exercise and Sale | 18,93 - 78,83 | 25,01k | - |
| 2025-08-29 | Dr. Henry PelishChief Scientific Officer | 5,01k | 4,99k | Derivative Exercise and Retained Stock | 0,87 - 1,08 | 38,48k | 14,96% |
| 2025-08-25 | Ms. Darlene NociChief Development Officer | -4,00k | 187,09k | Derivative Exercise and Sale | 27,85 - 75,63 | 7,08k | - |
| 2025-08-15 | Dr. James R. PorterCEO, President & Director | -27,00k | 1,53M | Derivative Exercise and Sale | 18,93 - 76,90 | 117,61k | - |
| 2025-08-07 | Dr. Henry PelishChief Scientific Officer | -5,50k | 259,26k | Derivative Exercise and Sale | 18,93 - 74,85 | 20,01k | - |
| 2025-07-30 | Ms. Darlene NociChief Development Officer | -4,00k | 210,04k | Derivative Exercise and Sale | 27,85 - 80,36 | 7,08k | - |
| 2025-07-15 | Ms. Alexandra BalcomCFO & Treasurer | -20,00k | 1,31M | Derivative Exercise and Sale | 18,93 - 85,48 | 20,78k | - |
| 2025-07-15 | Dr. James R. PorterCEO, President & Director | -27,00k | 1,71M | Derivative Exercise and Sale | 18,93 - 84,53 | 117,61k | - |
| 2025-07-10 | Dr. Henry PelishChief Scientific Officer | -5,50k | 281,78k | Derivative Exercise and Sale | 18,93 - 80,92 | 20,01k | - |
| 2025-07-09 | Dr. Henry PelishChief Scientific Officer | -2,15k | 174,08k | Automatic Disposition | 81,08 - 81,90 | 20,01k | -9,68% |
| 2025-06-27 | Ms. Alexandra BalcomCFO & Treasurer | -20,00k | 1,22M | Derivative Exercise and Sale | 18,93 - 80,02 | 20,78k | - |
| 2025-06-26 | Ms. Darlene NociChief Development Officer | -4,00k | 203,43k | Derivative Exercise and Sale | 27,85 - 79,15 | 7,08k | - |
| 2025-06-25 | Dr. Henry PelishChief Scientific Officer | -10,80k | 551,90k | Derivative Exercise and Sale | 27,85 - 79,92 | 17,78k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
